Results

Total Results: 7,637 records

Showing results for "therapy".

421. DEcIDE 32: The Incident User Design in Comparative Effectiveness Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
     May 01, 2012 - advantage of the incident user design is that it can capture the clinical consequences of an entire therapeutic … The risk of myocardial infarction associated with antihypertensive drug therapies. … Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled … Structural accelerated failure time models for survival analysis in studies with time- varying treatments … A review of uses of health care utilization databases for epidemiologic research on therapeutics.

422. Archived: Evidence Summary: Carotid Artery Stenosis: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/carotid-artery-stenosis-screening-july-2014
     July 08, 2014 - ; and would not have included treatments now considered to be current standard medical therapy, including … , primarily because medical therapy for trials was ill-defined, varying, and often lacked treatments … An assessment of clinically useful measures of the consequences of treatment. … Stenting versus endarterectomy for treatment of carotid-artery stenosis. … CREST-2: guiding treatments for asymptomatic carotid disease.

423. Recommendation #4 - Opioid Release Rate When Starting Opioid Therapy  | CDS Connect
     cds.ahrq.gov/cdsconnect/artifact/recommendation-4-opioid-release-rate-when-starting-opioid-therapy
     September 27, 2018 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

424. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0174_10-20-2009.pdf
     January 01, 2009 - devices Comparator(s): See above interventions and no treatment Outcome(s): Intermediate outcomes … What is the effectiveness and comparative effectiveness of physical and rehabilitative treatments available … What are the associated risks, adverse effects, and potential harms of physical and rehabilitative therapies … There is some indication that non-pharmacologic therapies are underutilized in patients with OA and … A review that evaluates the effectiveness of treatments and gaps that remain in the evidence for patient

425. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/36947/psn-pdf
     September 09, 2011 - The safety of warfarin therapy in the nursing home setting. … The safety of warfarin therapy in the nursing home setting. Am J Med. 2007;120(6):539-44. … https://psnet.ahrq.gov/issue/safety-warfarin-therapy-nursing-home-setting The anticoagulant warfarin … https://psnet.ahrq.gov/issue/safety-warfarin-therapy-nursing-home-setting https://psnet.ahrq.gov/issue

426. Nutrition as Prevention for Improved Cancer Outcomes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/improved-cancer-outcomes-protocol_0.pdf
     December 01, 2021 - characteristics (cancer type, treatment type (systemic therapy, radiation, surgery), stage of disease … cancer diagnosis and initiation of any cancer therapy (e.g., systemic therapy, radiation, surgery). … (at least in part) w ith cancer therapy (e.g., systemic therapy, radiation, surgery), regardless of … (at least in part) w ith cancer therapy (e.g., systemic therapy, radiation, surgery), regardless of … draft report, the search will be conducted from 2000 to December 2021 to encompass contemporary cancer treatments

427. Uspstfstatinuseforprimarypreventionofcvdinadults Change Log
     cds.ahrq.gov/sites/default/files/cds/artifact/logic/2024-08/USPSTFStatinUseForPrimaryPreventionOfCVDInAdults_Change_Log.txt
     January 01, 2024 - CDSConnectCommonsForFHIRv102 to version 2.1.0 - Replace extensional value set "Low intensity statin therapy … (currently expands to same codes) - Replace extensional value set "Moderate intensity statin therapy … (currently expands to same codes) - Replace extensional value set "High intensity statin therapy" … (currently expands to same codes) - Replace extensional value set "Moderate intensity statin therapy … (currently expands to same codes) - Replace extensional value set "High intensity statin therapy"

428. Autism-Update Clinician (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_clinician.pdf
     September 01, 2014 - Treatments for ASD focus on improving core deficits in social communication, addressing challenging … Individual goals for treatment vary by child, and a combination of therapies is used to achieve these … ., settings), components of multicomponent therapies that drive effectiveness, and predictors of treatment … � Re-evaluating potential treatments as research evolves. … � Available evidence on each program or therapy.

429. High-Cholestorol-Medicines-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
     February 01, 2014 - Effectiveness Reviews, the program supports systematic appraisals of existing scientific evidence regarding treatments … experimental and epidemiologic studies,4,5 therapeutic strategies to decrease risk have focused on … importance of patient-centered clinical outcomes for evaluating the effectiveness of lipid-modifying therapies … While our findings may suggest that one therapeutic option provides a benefit over another, we cannot … previous reviews on dietary modification and reduction of lipids and CVD risk, we did not include these therapies

430. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar-2010_research-protocol.pdf
     January 01, 2010 - diabetes in the United States. 3,4 Thus, a large segment of the population requires glucose-lowering therapies … insulin delivery and glucose monitoring for various populations of individuals with diabetes so that therapeutic … of individuals with diabetes who are receiving treatment in a usual care setting. … Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. … Continuous glucose monitoring and intensive treatment of type 1 diabetes.

431. Stem-Cell-Children Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
     February 01, 2012 - Effectiveness Reviews, the program supports systematic appraisals of existing scientific evidence regarding treatments … Treatment, therapy, or intervention -HSCT Intermediate Outcomes • Recurrence-free survival • … Treatment, therapy, or intervention -HSCT Intermediate Outcomes Slowing of the progression of or … Treatment, therapy, or intervention -HSCT Intermediate Outcomes • Stable source of endogenous … selection to the past 15 years to ensure that we identified evidence that is comparable in terms of therapeutic

432. Archived: Evidence Summary: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
     October 07, 2011 - Preventive Services Task Force evidence reviews on screening and treatments for prostate cancer. … There were 3 randomized trials and 23 cohort studies of treatments. … Few studies evaluated newer therapies. … Benefits and harms of treatments for prostate cancer were last reviewed by the USPSTF in 2002 8 . … Treatments for localized prostate cancer: systematic review to update the 2002 U.S.

433. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
     September 13, 2011 - may be extended up to 48 weeks for patients with HCV genotype 1.5,6 The effects of antiviral therapies … may change with the introduction of the new drug class.13,14 Adherence to treatments has been shown … treatment outcomes specifically in HCV antiviral therapy or whether treatment adherence interventions … training), increasing the convenience of medication use (e.g., simplifying drug dosing, tailoring the treatments … • Treatment regimens: prescribed antiviral therapy.

434. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - It is not known whether these therapies are better or worse than other treatments for localized prostate … [ti] OR therapies[ti] OR treatment*[ti] OR treating[ti] OR treat[ti] OR therapy/mh AND Limits … or received no initial treatment Clinical and biochemical out- comes of radiation therapies for … It is not known whether these therapies are better or worse than other treatments for localized prostate … The absolute risk of impotence and treatment-related morbidity appeared to be similar to other treatments

435. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - It is not known whether these therapies are better or worse than other treatments for localized prostate … [ti] OR therapies[ti] OR treatment*[ti] OR treating[ti] OR treat[ti] OR therapy/mh AND Limits … or received no initial treatment Clinical and biochemical out- comes of radiation therapies for … It is not known whether these therapies are better or worse than other treatments for localized prostate … The absolute risk of impotence and treatment-related morbidity appeared to be similar to other treatments

436. 6Ngc3Byq9Jeby Pwyvd6Or (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6Ngc3byQ9jeBy_pwyvD6or
     September 01, 2014 - ; and would not have included treatments now considered to be current standard medical therapy, including … , primarily because medical therapy for tri- als was ill-defined, varying, and often lacked treatments … An assessment of clinically useful measures of the consequences of treatment. … Stenting versus endarterectomy for treatment of carotid-artery stenosis. … CREST-2: guiding treatments for asymp- tomatic carotid disease.

437. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0119_06-17-2009.pdf
     January 01, 2009 - Completion Date: 1-12-10 1 Results of Topic Selection Process & Next Steps  Pharmacologic therapy … versus medical foods and nondietary approaches for the treatment of phenylketonuria (PKU) will go forward … They are also interested in the comparative cost effectiveness of these treatments. … Pharmacologic Therapy versus Medical Foods for the Treatment of Phenylketonuria (PKU) Nomination …  Historically, the treatment of PKU has relied on nonpharmacologic therapies, with affected individuals

438. CER 5 Renal Artery Stenosis NSD SJ Clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_overview.pdf
     June 24, 2014 - management era (i.e., since JNC-5 in 1993), what is the evidence on the effects of aggressive medical therapy … (i.e., antihypertensive, antiplatelet, and antilipid treatment) compared to renal artery angioplasty … What adverse events and complications have been associated with aggressive medical therapy or renal … What treatment variables are associated with improved or worse outcomes of renal artery angioplasty … designed to test whether renal-artery stenting, when added to protocol- driven contemporary medical therapy

439. Spotlight Case [MONTH] 2003 (ppt file)
     psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.149_slideshow.ppt
     May 01, 2007 - A phenobarbital level was 30 (therapeutic 10-40 mcg/mL) and phenytoin level was 19 (therapeutic 10-20 … Epilepsy and Treatment Epilepsy affects approximately 2 million people in the United States Antiseizure … medications are the primary mode of epilepsy treatment Medications successfully control seizures in … adjustments Changes in product appearance Phenytoin blood level Alterations in concomitant drug therapies … Collaborative drug therapy management by pharmacists--2003.

440. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - (Low) KQ2:  For  patients  with  RA,  do  drug  therapies  differ  in  their   … (Low) KQ3: For patients with RA, do drug therapies differ in harms, tolerability, patient adherence, … RA in subgroups of patients based on stage of disease, prior therapy, demographics, concomitant therapies … : a multiple-treatment Bayesian metaanalysis. … based on stage of disease, prior therapy, demographics, concomitant therapies, or comorbidities?